Cryptocurrency & Digital Assets

How one company turned its internal training program into a strategic powerhouse, earning a top award and creating a blueprint for the future of work.

At a top Paris expo, GUYU's biotech arm BioQ unveiled cellular anti-aging ingredients, signaling a new era of Chinese innovation in the beauty supply chain.

An innovative RNA-editing therapy for hepatocellular carcinoma has received a major FDA designation, potentially accelerating its path to patients.

Barings BDC maintained its dividend, but a dip in income and net asset value reveals underlying challenges in a volatile market for private credit.

Aptar Pharma and the FDA lead a critical mission to reinvent respiratory medicine, ensuring patient safety while tackling the climate impact of inhalers.

The biotech supplier swung to profitability and positive cash flow, driven by a major cost overhaul and strong demand in its core nucleic acid business.

AdCare Rhode Island consolidates services in North Kingstown, creating an integrated care hub to tackle addiction in one of the state's most underserved regions.

Job applications have tripled, but your chance of an interview is down 50%. New data reveals how AI is creating a tougher, more selective hiring market.

Rogers Corporation adds two powerhouse CEOs to its board, signaling a strategic push to dominate high-growth markets like EVs and advanced industrial tech.

Discover why Moscato d'Asti is shedding its old image, as its low-alcohol charm and versatility win over a new wave of global wine drinkers.

The world's largest cruise company simplifies its complex dual-listing, moving to Bermuda in a strategic bid to boost liquidity and shareholder value.

A new health campaign uses emotional appeals to boost adult vaccination in Southeast Asia, highlighting the complex role of pharma in public health.

A viral mascot mishap has inspired a Chinese city to launch an ambitious plan, leveraging sports and culture to attract global investment. Here's how.

With its 'Best Overall Platform' win, MedeAnalytics signals a shift from passive data analysis to AI-driven action in a data-saturated industry.

Digital dentistry leader Medit acquires Progressive Orthodontics, launching a new division to merge high-tech scanning with world-class clinical training.

The firm's oversubscribed Collateralized Fund Obligation highlights a major shift in how institutional investors access private markets.

Vancouver's ME Therapeutics will unveil its in-vivo immune reprogramming technology, a potential cancer treatment game-changer, to global investors.

In a deal valuing it at $20B, Payward acquires payments firm Reap, betting big on stablecoins to build the financial infrastructure of the future.

From the makers of the 'World's Best Tequila,' a new Reposado redefines aging with a unique blend of Sauternes, Sherry, and Bourbon casks.

The celebrated restaurant-recipe hummus from Philadelphia's Zahav is now in 32 GIANT stores, pitting its premium quality against grocery aisle titans.